A small pilot study involving 24 fibromyalgia patients showed 67% experienced moderate to significant pain reduction after 6 weeks of BPC-157 therapy at 400 mcg daily
Proteins, 93 (1), 209216
Dihexa has demonstrated remarkable results in preclinical (animal) studies, including significant improvements in synaptic density, neuronal survival, and spatial memory in rodent models of cognitive impairment
The syringe visuals above will update in real-time.
What they found that, at least for the gastrointestinal tract, oral administration of BPC 157 seems to be favorable Pentadecapeptide BPC 157 and the central nervous system (link) This great study was designed to look at the effectiveness of BPC-157 on things like Behavioral Disorders, Brain Lesions, and Spinal Cord Injury
By encouraging the removal of damaged skin components and promoting new cell growth, it contributes to a more refined and radiant complexion